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 Disclaimer
This report of the Great Lakes Water Quality Board is
a compilation of extended abstracts of presentations
made by participants at the Workshop on Scientific
Challenges for Regulatory Decision Making. The
views expressed in the report are those of the partici-
pants and do not necessarily represent the opinions
of the Water Quality Board or of the International
Joint Commission.
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Introduction
In June 1991, as part of the Workshop on a Shared Policy Vision for the Great Lakes, the Great Lakes Water
Quality Board asked Dr. Theodora Colborn to make a presentation on her recent synthesis of information
on chemically—induced alterations in sexual development. Dr. Colborn’s presentation was inﬂuential in
the formulation of the Water Quality Board’s recommendations for its 1991 Biennial Report concerning the
control of specific substances. These recommendations were incorporated by the International 10th
Commission into its Sixth Biennial Report on Great Lakes water quality to the governments of the United
States and Canada. One month later this topic was the subject of a workshop held at the Wingspread
Conference Center, Racine, WI, where scientists from 17 disciplines produced a Statement of Consensus
concerning the magnitude of the problem of chemically—induced alterations in sexual development. These
research findings have profoundly changed the thinking of the scientific community about the significance
of environmental chemicals in relation to fetal development.
Current water quality management develops and enforces objectives based on toxicity to aquatic life or on
risk assessment models for human carcinogenicity. The new evidence of effects on the developing fetus
poses a challenge to existing water quality policies and practice. The Water Quality Board held a Work—
shop on Scientific Challenges for Regulatory Decision Making to review the evidence and to determine
whether this topic should be recommended to the Commission as a priority for the 1993-95 Biennial Cycle.
The workshop was held on Monday, November 16, 1992 in the US EPA Region V office in Chicago,
Illinois.
Commissioner Gordon Durnil, in his opening
remarks, said that the period from 1989 to 1992 had
been an exciting period of progress in how the
Commission and its associated boards view water
quality problems in the Great Lakes. He noted the
change in the words we now use to describe the
problem and the statements we are prepared to make
in light of the new evidence. For instance, we talk
about persistent toxic substances as distinct from
toxic substances, and about injury to human health
and child development in addition to fish and
wildlife resources. Where in the past we only talked
about potential effects, we are now prepared to make
 
cause and effect statements based on the weight-of-
evidence approach. Where cancer was considered
the most serious end point, the seriousness of effects
on reproduction and embryo development is now
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ed.
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Part of the challenge in implementing many of the
Commission’s recommendations is that, in doing so,
the often separate and divergent sectors of scientific
research and the regulatory community must interact
in intricate ways. Each part of the community is
equally important. Scientists must do the research
which should provide the causal statements, and the
regulatory community must take appropriate action
based on these and other findings. This poses
questions about how much information is needed
before a policymaker changes a policy, or an industry
is required to change a process, or an individual
changes a lifestyle.
In her opening remarks, Dr. Theodora Colbom noted
the challenge of translating scientific evidence into
policy and regulation. As an example, she cited a
paper published in 1950 by Burlington and
Lindeman* from Syracuse University in which male
White Leghorn chicks, exposed to DDT during
hatching, failed to develop combs or to reach sexual
maturity. Despite this 40-year-old knowledge of the
developmental effects ofDDT on avian reproduction,
no action has been taken against DDT, based on
developmental effects, though action was taken
based on carcinogenesis. She noted that the scien-
tists themselves were not necessarily at fault, since
they are not, generally, publicists or lobbyists. The
regulators are not necessarily at fault because they
are frequently not given the power to address new
problems. Thus a new approach is needed to
translate science into a regulatory context and
specifically to deal with the new evidence concern—
ing developmental and transgenerational health
effects. Since exposures to chemicals that cause
these effects occur globally, she said that it is impera-
tive totake action to protect human civilization.
Dr. John McLachlan, Director of Intramural Research
at the National Institute of Environmental Health
Sciences at Research Triangle Park, North Carolina,
gave a presentation entitled “New Scientiﬁc Informa-
tion on Subtle Effects of Environmental Chemicals on
Fetal Development.” He organized his talk around the
following three issues:
* Burlington, H. and V.F. Lindeman. 1950. Eﬂect ofDDTon
testes and secondary sex characteristics of White Leghorn
cockerels. Proceedings of the Society for Experimental Biology
and Medicine. 74:48-51.
 
a] the fetus of the developing human being or animal
represents an especially sensitive target site for
environmental chemicals;
b] some environmental chemicals mimic biologically
important molecules such as hormones, nerve
stimulating chemicals and immunological chemicals;
c) the functionally significant effects caused by
these environmental chemicals are subtle and
thus difficult to measure and monitor.
Dr. McLachlan brieﬂy reviewed the history of the
development of teratology, the study of birth defects.
Before 1961, teratology was a small science, centred
at a laboratory in Cincinnati in which the deformities
induced by chemicals in the offspring of exposed
mice were studied. In 1961, the relevance of teratol—
ogy was heightened by the finding of the relationship
between phocomelia (extreme shortening of the
limbs) in infants born to mothers who had taken
thalidomide during pregnancy. In 1971, the science
was further transformed when transplacental carci-
nogenic effects were documented in post-pubertal
female offspring of women who had taken the
synthetic estrogen, diethylstilbestrol, during preg-
nancy. Transplacental exposure to environmental
chemicals, and estrogens in particular, were thus
shown not only to cause subtle effects such as cancer
but also immunological dysfunction, neurological
deficits, and long-term delayed effects. The Wing-
spread Conference in July 1991 further changed
perspectives on the science of teratology by showing
that several organochlorine and other chemicals
found in fish, wildlife and human tissue samples
were hormone disruptors and thus could inﬂuence
fetal development.
Thirty years ago, the placenta was thought to protect
the fetus from environmental chemicals in the
pregnant mothers. It is now well established that a
wide variety of chemicals can reach the human fetus
as well as developing fetuses of wildlife. In the
pregnant mother and developing fetus, a large part of
the estrogens they produce are bound to an extracel-
lular binding protein called (x—fetoprotein, or are
metabolized by the placenta. But in the case of
diethylstilbestrol and other synthetic compounds
with estrogenic activity, they do not seem to interact
with these protective mechanisms of the fetus.
Knowledge is increasing on how the development of
the reproductive tract and its structure and function
 
 are physiologically controlled in mammals. For
example, there is a period of time after conception, at
the beginning of development of all mammalian and
avian fetuses, in which both male and female repro-
ductive systems are present. In mammals, all fetuses
are destined to be females without the genetic
activation from the Y chromosome (male) to make a
product that turns the developing gonad into a
testicle. The testicle in turn makes two other hor-
mones, male sex hormone and a protein that causes
the female reproductive system to disappear. This
process of sex differentiation can be reversed by
exposing the developing fetus to female sex hor-
mones. For instance, if diethylstilbestrol or estrogen
is given to a pregnant mouse, the male offspring will
look normal, produce testosterone and behave like
males. But they will have undescended testicles and
associated epididymal tubes, which remain in the
abdomen. These mice will still make male hormone
and sperm, but adjacent to these structures the
mouse will have the female organs as well, including
the fallopian tubes, oviducts, a uterus, cervix and the
upper part of the vagina. Further, male mice that
have been exposed to diethylstilbestrol in utero have
even been shown to develop uterine cancer. Estro-
gens and estrogen-like compounds can thus affect the
process of sex differentiation or sexual development
in many profound but subtle ways.
The timing of exposure to these hormones and
biomolecules will determine the outcome in predict-
able ways. Speciﬁc genes are activated and
deactivated at speciﬁc times to start and end these
processes. If the process described above is inter-
rupted with estrogen, it will irreversibly preserve
hermaphroditic structures. The endocrine system
integrates the development and functioning of many
organs, including the brain, the nervous system and
the immune system. These systems can therefore be
irreversibly compromised by what happens during
development through exposures to environmental
chemicals. Because the effects during fetal develop-
ment are irreversible and persist long after the
estrogen-like substances or other molecules that
caused the effect have disappeared, it is difficult to
establish a causal relationship through chemical
analytical techniques.
When given to adult males, estrogen and estrogenic
compounds cause breast enlargement, shrinkage of
 
the testicles and decrease in sperm count and libido.
A recent publication*, reviewing 61 different publi-
cations on sperm counts and quality inmen in the
Western world, showed a decrease in sperm over the
past 40 years. An accompanying editorial raised the
possibility that this might be consistent with an
increase in environmental chemicals that act as
hormones. The editorial also suggest that in utero
exposure to environmental estrogens such as PCBs or
DDT may have inhibited full development of the
sperm-producing organs in men worldwide.
Many chemicals in our environment mimic biologi-
cal molecules. Some chlorinated hydrocarbons such
as DDT, PCB and dioxin show estrogenic activity and
function like weak diethylstilbestrol molecules by
reversing the process of male sexual differentiation in
embryos of birds, mammals and turtles. They are
ubiquitous, persistent and bioconcentrated to levels
associated with the subtle effects. In addition, many
different kinds of plants make their own female
hormones. Environmental estrogens can cause
hormonal effects on mammals that eat them. Assay
methods have been developed to measure estrogenic
activity of chemicals, based on the ability of an
estrogen receptor molecule to recognize estrogen-like
substances. Some PCBs have been tested in this
assay and have been shown to be recognized by the
estrogen receptor.
In the research area, we need to find biomarkers that
can indicate the genes and their products that are
irreversibly affected. When we understand the
biological mechanisms of action of the molecules, we
may be able to prevent damage. For instance,
diethylstilbestrol has been used as a metaphor of how
certain molecules can affect fetal development. The
same principles are being established for the effects
of environmental chemicals on the nervous system,
the immune system and on the skin. For example,
pregnant mice given a carcinogen that induces skin
cancer have offspring that do not exhibit skin cancer.
But if these offspring are subsequently exposed to a
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Dr. Andrew Gilman, Chief of the Great Lakes Health
Effects Program of Health and Welfare Canada in
Ottawa, Ontario, gave an overview entitled “The
Effects of Contaminants on Human Health: The Old
and the New.” He prefaced his remarks by noting
that the recent integration of knowledge, as outlined
by Dr. Colborn and Dr. McLachlan, has brought new
insight into the significance of exposures to environ-
mental chemicals. It is extraordinarily difficulty,
however, to communicate information to the public
in a credible way. In addition, the public expects
that science is going to deliver the required evidence,
but it has proved difﬁcult to detect attributable
effects in human populations exposed to environ-
mental chemicals, because of confounding factors.
Government action to control environmental chemi-
cals does not have to wait, however, until everything
is known about the substances.
Dr. Gilman compared current and new health
endpoints. Cancer, birth defects and organ toxicity
such as kidney or lung disease, and liver dysfunction
have been useful measures of health for a long time.
Neurotoxic effects such as brain and nerve damage
have been demonstrated for exposures to various
drugs and contaminants through behavior testing.
More sensitive neurotoxic effects can be measured,
such as delayed effects in adults through somatosen-
sory testing and developmental neuropathy in
infants, through measuring attention span, learning
and pattern discrimination. Traditional measures of
reproductive toxicity have included fertilization and
implantation rates as well as embryo and fetal
toxicity. Newer reproductive measures include the
incidence of sexual dysfunction, changes in hormone
regulation, changes in the age of onset of menstrua-
tion and of menopause, and changes in birth
characteristics such as gestational age, birth weight,
length and head circumference. Various aspects of
genetic toxicity of compounds have also been
measured, including embryo death associated with
genetic alterations, miscarriages and various syn-
dromes. Immunotoxicity is a rapidly expanding field
with assays being developed on an international
basis to measure immune impairment or imbalance.
Some immune response in the population seems to
be expressed as a general increase in hypersensitiv-
ity, allergy, asthma and low-level morbidity.
Because health is also considered to be the start of
well-being as well as an absence of disease, there has
  
been a growing interest in social impacts of contami-
nants on altered lifestyles. Examples of measures of
psycho-social health include exercise opportunities
in urban centers related to space and ground level
pollution, willingness to commute longer distances
between jobs and a preferred living space, alterations
in diet to improve health and reduce contaminant
exposure, socio—economic and cultural impacts on
communities from pollutants, urban odours and the
incidence of depression.
Dr. Gilman noted the widespread misperception
about what realistically could be detected from
studying human exposures to chemicals. He re-
viewed the advantages and disadvantages of studying
laboratory animals, wildlife and humans to detect
environmental impacts on human populations.
Though direct causal statements can be made about
effects of specific substances on laboratory animals,
the information must be extrapolated for use in
humans. Causal statements about the effects of
pollution on wildlife species are indirect and of a
correlative nature, yet they reﬂect the real world
exposures to mixtures of environmental pollutants.
The results from wildlife studies also must be
extrapolated for use on humans. Though information
on the effects of chemicals on humans is correlative
and thus subject to potential confounding factors, no
extrapolation between species is required to interpret
the information. Most endpoints are easily measured
in laboratory animals and many are also measurable
in wildlife, but it is difﬁcult to obtain many kinds of
data on humans, particularly those concerning some
aspects of reproduction and genetic toxicity and
delayed neurotoxic effects. Experimentation with
individuals or populations is generally unethical and
gathering data from individuals is subject to
misreporting, and gathering samples is too invasive.
In assessing the risks posed by contaminants, regula-
tory agencies have applied a weight-of—evidence
approach to obtain information on all routes of
exposure, congruity between studies, reliability,
consistency of outcome, and biological plausibility.
In synthesizing an overall assessment, information
concerning laboratory animals, wildlife and human
populations is now being combined, whereas previ-
ously, only information on wildlife and laboratory
animals or on laboratory animals and human popula—
tion was used. It is essential in making decisions on
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chemicals, that a sound scientific basis be used,
because any irrelevant or frivolous regulation can
end up in court. By using a sound scientiﬁc basis
for decision making, a preventive approach can be
initiated based on what is known now, even while
further research is undertaken. Science cannot
answer — or would take too long to answer - all the
questions if regulations are to be based on com-
plete knowledge. Rather regulatory action must be
based on the best available knowledge.
A balance between the traditional and the new
research studies is needed. For instance, some
classic 90-day toxicity studies still must be
undertaken for a range of individual chemicals.
New studies also must be undertaken on delayed
neurotoxicity, the effects of hormone mimics on
reproductive outcomes, and the effects of mixtures
of contaminants found in food such as in Great
Lakes fish on several generations. In epidemiol-
ogy, there must be classic case control studies as
well as newer approaches to preparing atlases of
cancer and congenital anomalies for hypothesis
generation. Surveillance activities must continue
to document human exposure to contaminants by
monitoring breast milk, blood, food, air and water.
In addition, new studies on reproductive effects
are needed to monitor levels of pollutants in
follicular ﬂuid that bathes the ovum in the female
and influences egg cleavage. New initiatives are
needed to store tissue samples for retrospective
analysis ofsamples through tissue banking for
contaminants and microbiological agents. Knowl-
edge about these and other advances have been
shared between scientists at conferences but it is
increasingly important to bring together scientists
from several countries for direct consultation on
research planning and evaluation of speciﬁc
issues. In addition to classical public opinion
polls, site visits and community consultation are
increasingly used to ﬁnd out what people are
really concerned about. U.S. and Canadian
scientists have traditionally worked together in
partnerships, but joint projects must also be
undertaken with other nations or communities,
especially in Europe. Innovative sources of
funding, in partnership with health, ﬁsheries and
wildlife researchers, anthropologists, sociologists,
psychologists, economists and others may evolve
from this expanded consultative process.
 
Levels of persistent organochlorine chemicals
declined rapidly in the Great Lakes up until about
1983. Since the mid-19803 levels of most persistent
toxic substances have not decreased very rapidly,
primarily as a result of environmental cycling of
substances. As levels have declined, more sensitive
techniques have been developed to detect effects.
Some techniques that measure endpoints such as
neurological development, somatosensory effects,
neurotransmitter effects and hormonal dysfunction,
have low speciﬁcity for the causes and thus there is
potential for confounding factors to give specious
associations.
Dr. Larry Reiter, Laboratory Director of the U.S. EPA
Health Effects Research Laboratory, Research Tri-
angle Park, North Carolina outlined three major
changes that have been instituted in his laboratories
to respond to the new information concerning subtle
effects of environmental chemicals. The ﬁrst change
is in context. U.S. EPA is a regulatory agency and
research therefore must be mission oriented. The
new evidence of subtle effects, however, suggests that
U.S. EPA should reorient some of its work to solving
specific environmental health problems. To this end,
U.S. EPA has extended the use of the 1983 risk
assessment paradigm developed by the National
Academy of Sciences as a conceptual framework to
consider different environmental health problems
and priorize those that pose the greatest risk. This
has brought about the second change which is in
terms of organization. The laboratory is now struc-
tured according to scientiﬁc as well as regulatory
programs to ensure scientific excellence and program
relevance. The objective is to improve communica-
tion between those responsible for setting standards
and maintaining regulatory programs, and those
responsible for scientiﬁc leadership and direction to
the research program. The third organizational
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chemicals and, as a regulatory agency, to control
these exposures. There is a series of intervening
events between human exposure and the manifesta-
tion of health effects. These events include
absorption of the dose, dose to the target organ, and
the consequent biological effect resulting in a health
effect. Frequently information on these pharmacoki-
netic processes is inadequate to build a predictive
model to understand these relationships. Many
newly recognized subtle effects that result from
perinatal exposures to chemicals do not manifest
themselves until later in the life of the organism.
Thus there is a temporal disconnect between the
exposure and the resulting health effect, which poses
further complexity in understanding the relationship
between exposure, absorbed dose, target dose,
biological effect and adverse outcome. A second
difﬁculty arises from the speciﬁcity ofthe mechanism
of action for some compounds. A compound that
affects a hormone receptor can express its action at a
concentration far below the concentration that would
interfere with the basic metabolic processes in cells.
There are three distinct, but interrelated, activities
that the US. EPA undertakes to focus regulatory
decisions on the appropriate risks. These include:
a) scientific research to generate the data on the
determinants of environmental health effects;
b) risk assessment to interpret the data or hazard,
dose-response and exposure to estimate the
likelihood and magnitude of the human health
risks; and
c) risk management to apply the data to decide
which risks are unacceptable and how they
should be addressed through public information,
standards, technology or regulatory prohibitions.
In performing risk assessments and discussing risk
management it frequently becomes clear what
signiﬁcant information is still required, thus it is
important that information about these research
needs and data gaps is given to those involved in the
scientiﬁc research. In this regard U.S. EPA has
identified the following three generic areas of
research to support risk assessment:
a] state of the science biological assays;
b) predictive models; and
c) chemical speciﬁc data.
 
For instance, in the assessment of the risks of
perinatal exposure to potential neurotoxic agents, in
addition to the general need for biological assays,
there is a speciﬁc need to investigate the long-term
developmental implications for the nervous system
of fetal exposures to organophosphates and carbam-
ates, which cause acetyl cholinesterase inhibition, on
learning and memory. Similarly, specific biomarkers
are needed to evaluate exposure and interaction with
target tissue for carcinogens. In the regulatory
decision making process, the time when the agency
could rely completely on data on effects on labora-
tory organisms has passed and thus there is a need
for predictive models. The development of quantita-
tive risk assessment models will require an
understanding of the underlying biological processes,
particularly as it relates to pharmacokinetics. For
instance, in the re-evaluation of the risks posed by
dioxins and mixtures of dioxin-like PCBs, advances
have been made through understanding the mecha-
nism of action and the relationship between the
toxicological potencies ofthe compounds and their
binding afﬁnities to the Ab receptor.
The US. EPA Health Effects Research Laboratory is
structured to address not only the major health
endpoints ranging from neurotoxicity, pulmonary,
developmental, immunologic, genetic, carcinogenic
to pharmacokinetic endpoints, but also the different
levels of biological organization ranging from mo-
lecular, cellular and tissue through organ systems,
whole organisms, to the population level. Both these
multidimensional and multidisciplinary approaches
are required to develop information needed to assess
risks relevant to U.S. EPA regulatory programs for
air, water, toxics, pesticides and hazardous wastes.
Dr. Reiter gave an overview of the research on ozone
and on non-cancer health effects to illustrate how the
agency has been coordinating research using toxicol-
ogy, clinical studies and epidemiology approaches.
About 90 million people in the US. live in areas that
are not in compliance with ozone standards. Research
on the health effects of ozone has changed from acute
effects to those effects resulting from chronic expo-
sures. This change reﬂects the amendments to the
Clean Air Act that address the issue of non-attainment
of the standards. Several research questions exist
concerning exposure scenarios, dose-response relation-
ships, cross—species extrapolation, pulmonary
functioning and cumulative effects of acute episodes
  
 versus chronic low level exposure. Through
interagency meetings between US. EPA, the California
Air Resources Board and the National Institute of
Environmental Health Sciences, a coordinated re-
search program has evolved to undertake the needed
toxicological, clinical and epidemiologic studies.
The second example concerns the US. EPA dioxin
re-evaluation. It has recently become clear that
although current risk assessments are based on
cancer, several studies suggest that reproduction and
development are more sensitive endpoints than
cancer. U.S. EPA has set up a multidisciplinary
program to replicate and extend the various observa-
tions. Researchers will study the multiple health
effects of perinatal exposure to TCDD, including
effects on male and female reproduction, and
neurobehavioral and immune responses. These
studies will be compared with information on the
target dose derived from pharmacokinetic modelling
to investigate whether there are critical periods of
exposure for different kinds of health effects. It may
be possible to extend these studies to obtain general—
ized findings from a variety of laboratory animal
species, and to extend these findings not only to the
dioxin-like PCBs but also to the non dioxin-like
PCBs. Understanding the mechanisms of action is
emphasized for which there will be a need for further
development of methods.
Dr. Iim Donald, Acting Chief of the Reproductive
Toxicology Unit of the California EPA, gave a
presentation on the reorganization that has taken
place in California State Government. He explained
how California established an Environmental Protec-
tion Agency in July 1991 to consolidate many of the
different environmental regulatory functions that
were spread between various disparate agencies.
One of the half-dozen boards and departments that
were brought together or created was the Ofﬁce of
Environmental Health Hazard Assessment(OEHHA).
This is now the primary department in California
government for risk assessment, and uses the risk
assessment model developed by the National Acad-
emy of Sciences as the basis for its regulatory
framework.
A copy of the Wingspread statement was referred to
Dr. Donald’s Unit for review. The result of the
 
review was that there was a need for a re-evaluation
of the capability of scientific departments of the state
for risk assessment for subtle ecological effects, as
opposed to human health effects. OEHHA formed a
working group to identify California departments and
programs involved in ecological risk assessment. In
essence there are two agencies in California that have
this capability and mandate; the California Environ-
mental Protection Agency, and the Resources
Agency. Dr. Donald reviewed the several parts of
these organizations that have this responsibility.
California has a fairly large number of scientists and
extensive expertise spread across a variety of differ-
ent groups and organizations. There is a need to
integrate the expertise to formulate the best plan and
best methods available for ecotoxicological risk
assessment. Through the OEHHA working group,
departments, particularly in the same agency, have
an understanding of each others work. The working
group is preparing an overview plan to review what
research has and has not been done. For example,
some gross endpoints such as lethality and congeni-
tal abnormalities in birds have been adequately
addressed, but further work is needed on the subtle
endpoints such as disruption of the endocrine,
immune or nervous system. Through the preparation
of a long-term plan, the working group will propose a
coordinated approach to ecotoxicological risk
assessment in California.
Dr. Gerald Pollock, Acting Chief of the Fish and
Sediment Contamination Evaluation Unit ofthe
California EPA, described the activities being under-
taken to document chemical contamination of fish,
the Bay Protection and Toxic Cleanup Program, and
on the opportunities for institutional adaptation in
the area of ecotoxicology.
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dioxins and furans. As a result, a risk assessment
map was prepared and a consumption advisory
issued to sport anglers.
Two years ago, the Governor of California signed a
bill to establish The Bay Protection and Toxic
Cleanup Program. Under this bill, the Office of
Environmental Health Hazard Assessment and the
Department of Fish and Game are mandated to assist
the State Water Resources Control Board to establish
sediment quality objectives based on protection of
human health and aquatic life. A strategy is being
prepared to address persistent toxic substances that
contaminate sediments and biomagnify in food
chains, resulting in high exposures to ﬁsh—eating
wildlife and humans.
The juxtaposition of the development of sediment
quality objectives for protection of aquatic life and
for human health has been a significant institutional
adaptation. In addition to conducting acute toxicity
studies, the Department of Fish and Game is develop-
ing bioassays to determine the toxicity of these
compounds to early larval forms. Particular attention
will be given to subtle endocrine effects, particularly
as it relates to reproductive toxicity. Much of the
resources for this initiative is going into this
ecotoxicological research rather than into human
health. However, sediment objectives will involve
an interagency collaboration rather than on the basis
of a single narrow mandate, which is an innovative
development.
Mr. Jim Armstrong, Chief of Controls Division of the
Commercial Chemicals Branch of Environment
Canada, described the assessment and control
processes under the 1988 Canadian Environmental
Protection Act. The purpose of the presentation was
to show how new information, such as that on subtle
developmental effects, would be incorporated into
the assessment and regulatory processes. The
Canadian Environmental Protection Act is the
principal piece of Canadian federal environmental
protection legislation and the toxic substances part is
central to this act. The act’s deﬁnition of toxic
substances is broad and comprehensive, and relates
to substances that enter or may enter the environ-
 
ment in a quantity or concentration or under condi-
tions that:
a) have a harmful effect on the environment; or
b) present or can present a danger to the environ-
ment on which human health depends; or
0) present a danger to human life or health.
Mr. Armstrong explained the process of preparing a
list of priority substances for detailed assessment.
The assessment is based on supportable science to
determine whether the priority substance is toxic
based on a weight-of—evidence approach. If the
Minister of the Environment and the Minister of
National Health and Welfare decide that a substance
is toxic, they must publish what regulatory controls
they intend to implement. After a socioeconomic
assessment has been made, the ministers may
approve and promulgate the regulations.
Mr. Armstrong noted the regulations that were
promulgated since 1977 on the import, manufacture,
distribution, sale and release of polychlorinated
biphenyls, terphenyls, polybrominated biphenyls
and mirex and on the manufacture and use of
chloroﬂurocarbons. The next real challenges are
regulations for polychlorinated dibenzo-p-dioxins
and dibenzofurans from pentachlorophenol manufac—
ture, chemical treatment and preservation of wood,
municipal incinerators, and pulp and paper mills
using chlorine bleach. The adsorbable organically
bound chlorine (AOX) in pulp and paper mills was
thought to be a causal agent in the toxicity of mill
efﬂuents. However, the situation is more complex
and regulation of pulp and paper mills based on AOX
does not seem to be a viable option.
In summary, he stated that the act and the deﬁnitions
under the act are sufficiently broad and comprehen—
sive to accommodate consideration of the substances
causing the subtle effects previously described. The
substances must be added to the list of priority
substances to be assessed in detail, using supportable
science to persuade the people who must make the
decisions about whether and how to regulate the
substances.
 
 Discussion
There was extensive discussion after the presenta—
tions. The following are some of the topics
addressed.
The traditional concern has been with substances
that are persistent, toxic and bioconcentrated.
Several substances such as PCB, dioxin and DDT that
have these characteristics can cause subtle effects on
the developing fetus. However, because there are
short, critical periods during development, maternal
exposure, to non persistent, toxic substances that are
not bioconcentrated, can result in irreversible subtle
damage to the developing fetus. Of particular
concern are the effects of maternal exposures to
organophosphates and carbamates on fetal neurologi-
cal development.
Groups of organisms and subpopulations ofhumans
are highly exposed because of the food they eat.
Some aboriginal people eat foods at the end of long
and complex food chains. Some eat predators such
as seals, whales, wolves, cougar and wildcat. The
resulting contamination by persistent toxic sub-
stances can be seen most dramatically in analyses of
breast milk samples from northern communities.
Those that live on food from terrestrial sources have
levels that are appreciably lower than those depen—
dent on marine ecosystems. Since certain wildlife
species are generally more contaminated than
humans, ambient environmental quality standards to
protect and restore affected wildlife may need to be
more stringent than for protection of human health.
Wildlife have been useful indicators of environmen-
tal quality in relation to persistent toxic substances.
The early observations and research on congenital
anomalies and embryo mortality in wildlife were
slow to inﬂuence researchers of reproduction and
development in humans. Even now, the wildlife and
health communities still undertake their work
without sufﬁcient consultation with eachother.
Many more measurements, which have traditionally
been undertaken on laboratory animals or on hu-
mans, could be applied to understanding
toxicological problems in wildlife.
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In the future, there will likely be much more research
oriented to understanding mechanisms of action in
order to predict the toxicological characteristics of
chemicals. With improved knowledge of biological
processes and the mechanism of toxic action, testing
strategies can be developed including more effective
in Vitro assay systems to undertake quantitative risk
assessment.
For biological research undertaken for regulatory
purposes, as well as advances in toxicology and
epidemiology, there must be improvements in
information sciences. Advances in computers and
other electronic technology, such as Virtual reality,
may be used together with the intuitive senses of
some brilliant minds to bring about progress in
estimating risks, particularly from exposures to
multiple chemicals. Too frequently in research for
regulatory purposes, there is not enough time to sit
and think about the data and to try to fit the pieces of
evidence together, not only to develop conclusions
but also to put forward new hypotheses.
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chemicals that have been identified. Since many of
the chemicals that have been identified as disrupting
the endocrine systems are pesticides, a systematic
process is needed to evaluate new pesticides and re-
evaluate existing pesticides for these kinds of effects.
Elaborate processes in both countries seek to build
consensus on whether a substance should be as-
sessed in detail and whether it should be regulated.
More information from laboratory experimentation,
human epidemiology and wildlife epizootiology is
being integrated. To obtain this level of integration
some jurisdictions have evenreorganized or insti-
tuted a new agency. Some decision making
processes have even been shared between existing
agencies. In one jurisdiction, regulatory decisions
Based on the presentations and on the discussion
that followed, the Board made the following conclu-
sion and recommendations:
The Board concludes that there is a need for
improvement in the integration of research
findings and information on human, fish and
Wildlife health effects caused by endocrine
disruptors.
The Board recommends that the Parties under-
take improvements in institutional mechanisms,
including: holding multidisciplinary workshops
on specific biological effects; publishing inte-
grated research findings in a manner that is
comprehensiblefor regulatory action; establish-
ing the requisite authority as well as
responsibility, if necessary through legislation
and allocation ofsuitable resources.
The Water Quality Board recommends that the
International [oint Commission hold workshops
during the 1993-95 Biennial Cycle on the effects
of chemicals on embryo development. The
following subjects might be considered:
   
can be swiftly inﬂuenced through the provision of
new information. Mechanisms are well established
in both countries to appeal or challenge a proposed
regulation or ruling.
The assessment process, though it relies on scientific
evidence from many sources and disciplines, neces-
sarily must use a weight-of-evidence approach.
There are uncertainties implicit in this process and
challenges, not only in building consensus for action
but also in communicating policy despite these
uncertainties. Occasionally, past policy has been set
based on political exigency, and scientists and the
regulatory community have been directed to prepare
the science to support the policy decision.
1) Deﬁnition of information needs for regula-
tory decision making on existing chemicals
and the application to a weight-of-evidence
approach;
2) The role ofpersistent toxic substances in the
demise and recoveryfailure of Great Lakes
lake trout (possibly to be undertaken in
conjunction with the GreatLakes Fishery
Commission);
3) Recent advances in embryo neurotoxicity and
immunotoxicity;
4) Application ofnew information technology to
the integration ofinformation on chemicals
that cause subtle effects on development of
vertebrates;
5) Improvements in knowledge ofbiological
processes and mechanisms ofaction for pre-
diction ofthe toxicological action of
chemicals.
The Great Lakes Water Quality Board recom-
mends that the Parties include the factor of the
ability ofsubstances to disrupt endocrine sys-
tems, particularlyfor embryos, in the evaluation
ofnewpesticides and re-evaluation of existing
pesticides.
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